ClinVar Genomic variation as it relates to human health
NM_000278.5(PAX2):c.76dup (p.Val26fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000278.5(PAX2):c.76dup (p.Val26fs)
Variation ID: 156297 Accession: VCV000156297.59
- Type and length
-
Duplication, 1 bp
- Location
-
Cytogenetic: 10q24.31 10: 100749771-100749772 (GRCh38) [ NCBI UCSC ] 10: 102509528-102509529 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 27, 2014 Oct 20, 2024 Aug 5, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000278.5:c.69_70insG MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_000278.5:c.76dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000269.3:p.Val26fs frameshift NM_000278.5:c.76dupG MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_000278.3:c.69_70insG NM_000278.3:c.76dup NM_001304569.2:c.169dup NP_001291498.1:p.Val57fs frameshift NM_003987.5:c.76dup NP_003978.3:p.Val26fs frameshift NM_003988.5:c.76dup NP_003979.2:p.Val26fs frameshift NM_003989.5:c.76dup NP_003980.3:p.Val26fs frameshift NM_003990.3:c.76dup NM_003990.3:c.76dupG NM_003990.4:c.76dup NM_003990.5:c.76dup NP_003981.3:p.Val26fs frameshift NC_000010.11:g.100749778dup NC_000010.10:g.102509535dup NG_008680.2:g.19070dup - Protein change
- V26fs, V57fs
- Other names
- -
- Canonical SPDI
- NC_000010.11:100749771:GGGGGGG:GGGGGGGG
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PAX2 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
477 | 499 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (9) |
criteria provided, multiple submitters, no conflicts
|
Nov 12, 2023 | RCV000014806.35 | |
Pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Feb 17, 2022 | RCV000144381.32 | |
Pathogenic (6) |
criteria provided, multiple submitters, no conflicts
|
Aug 5, 2024 | RCV000587907.11 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 26, 2024 | RCV001068182.8 | |
Pathogenic (1) |
no assertion criteria provided
|
May 27, 2019 | RCV001328165.2 | |
Likely pathogenic (1) |
no assertion criteria provided
|
Apr 17, 2019 | RCV001849315.2 | |
PAX2-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Apr 9, 2024 | RCV004532628.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Dec 07, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV000928103.1
First in ClinVar: Jul 30, 2019 Last updated: Jul 30, 2019
Comment:
Patient analyzed with Cystic Kidney Disease Panel
|
|
|
Pathogenic
(Apr 26, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
de novo,
germline
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Accession: SCV001149865.1
First in ClinVar: Feb 03, 2020 Last updated: Feb 03, 2020 |
Observation 1:
Sex: male
Tissue: blood
Observation 2:
Sex: female
Tissue: blood
|
|
Pathogenic
(Feb 17, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000490687.5
First in ClinVar: Oct 06, 2014 Last updated: Mar 04, 2023 |
Comment:
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published … (more)
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect in a mouse model for the variant exhibiting defects of the kidney, optic nerve, and retinal layer (Favor et al., 1996); This variant is associated with the following publications: (PMID: 23800802, 26489027, 24429398, 23539225, 22350371, 17541647, 21380624, 15808183, 8589702, 27226968, 20075965, 32164334, 10533062, 32203253, 33945118, 34217267, 32359821, 32604935, 33781268, 30937553, 31001663, 23966757, 8943028) (less)
|
|
Pathogenic
(Sep 14, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Focal segmental glomerulosclerosis 7
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Accession: SCV004045810.1
First in ClinVar: Oct 21, 2023 Last updated: Oct 21, 2023 |
Number of individuals with the variant: 1
Clinical Features:
Renal hypoplasia (present) , Stage 5 chronic kidney disease (present) , Growth delay (present) , Chronic kidney disease (present)
|
|
Pathogenic
(Jun 26, 2017)
|
criteria provided, single submitter
Method: research
|
Focal segmental glomerulosclerosis 7
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Study: Broad Institute Center for Mendelian Genomics (CMG)
Accession: SCV000693891.1 First in ClinVar: Mar 17, 2018 Last updated: Mar 17, 2018 |
Comment:
De novo variant in proband with FSGS, maternity and paternity confirmed (PS2).
Number of individuals with the variant: 1
Clinical Features:
Focal segmental glomerulosclerosis (present)
|
|
Pathogenic
(Feb 01, 2020)
|
criteria provided, single submitter
Method: research
|
Renal coloboma syndrome
Affected status: yes
Allele origin:
de novo
|
Molecular Biology Laboratory, Fundació Puigvert
Study: KidneyPanel_2020
Accession: SCV001425136.1 First in ClinVar: Jan 17, 2021 Last updated: Jan 17, 2021 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: research
|
Focal segmental glomerulosclerosis 7
Affected status: yes
Allele origin:
germline
|
Precision Medicine Center, Zhengzhou University
Accession: SCV001593015.1
First in ClinVar: May 14, 2021 Last updated: May 14, 2021 |
Comment:
PVS1:Null variant in the gene with established LOF as a disease mechanism PM2:at extremely low frequency in gnomAD PP3:Multiple lines of computational evidence support a … (more)
PVS1:Null variant in the gene with established LOF as a disease mechanism PM2:at extremely low frequency in gnomAD PP3:Multiple lines of computational evidence support a deleterious effect on the gene or gene product (less)
|
|
Pathogenic
(Jan 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Focal segmental glomerulosclerosis 7
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002059196.1
First in ClinVar: Jan 15, 2022 Last updated: Jan 15, 2022 |
Comment:
Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported … (more)
Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least two similarly affected unrelated individuals (3billion dataset). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000156297, PMID:8589702, 3billion dataset). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Focal segmental glomerulosclerosis (present)
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Lifecell International Pvt. Ltd
Accession: SCV003842253.1
First in ClinVar: Mar 26, 2023 Last updated: Mar 26, 2023 |
Comment:
A Heterozygous Frameshift variant c.69_70insG in Exon 2 of the PAX2 gene that results in the amino acid substitution p.Val26fs*28 was identified. The observed variant … (more)
A Heterozygous Frameshift variant c.69_70insG in Exon 2 of the PAX2 gene that results in the amino acid substitution p.Val26fs*28 was identified. The observed variant is novel in gnomAD exomes and genomes. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic (Variant ID: 156297). This variant has been identified in individuals associated Papillorenal syndrome (Ohtsubo H et al., 2012). Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines. (less)
Ethnicity/Population group: Asian
Geographic origin: India
|
|
Pathogenic
(Nov 10, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
Affected status: yes
Allele origin:
unknown
|
Daryl Scott Lab, Baylor College of Medicine
Accession: SCV004102721.1
First in ClinVar: Nov 20, 2023 Last updated: Nov 20, 2023 |
|
|
Pathogenic
(Jan 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
Focal segmental glomerulosclerosis 7
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001233276.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 28, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Val26Glyfs*28) in the PAX2 gene. It is expected to result in an absent or disrupted protein … (more)
This sequence change creates a premature translational stop signal (p.Val26Glyfs*28) in the PAX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAX2 are known to be pathogenic (PMID: 11461952, 24676634, 35444690). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with PAX2-related disorders (PMID: 24429398, 27226968). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 156297). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Nov 12, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
Affected status: yes
Allele origin:
unknown
|
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne
Accession: SCV005016512.1
First in ClinVar: May 01, 2024 Last updated: May 01, 2024 |
|
|
Pathogenic
(Nov 01, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001250388.26
First in ClinVar: May 09, 2020 Last updated: Oct 20, 2024 |
Number of individuals with the variant: 1
|
|
Pathogenic
(May 19, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
Focal segmental glomerulosclerosis 7
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002790410.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Focal segmental glomerulosclerosis 7
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Molecular Genetics, Royal Melbourne Hospital
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV004812605.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
Comment:
This sequence change in PAX2 is a frameshift variant predicted to cause a premature stop codon, p.(Val26Glyfs*28), in biologically relevant exon 2 of 11 leading … (more)
This sequence change in PAX2 is a frameshift variant predicted to cause a premature stop codon, p.(Val26Glyfs*28), in biologically relevant exon 2 of 11 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism. The highest population minor allele frequency in the population database gnomAD v4.0 is 0.0003% (3/1,110,572 alleles) in the European (non-Finnish) population. This variant has been reported in multiple unrelated individuals with a phenotype consistent with PAX2-related renal disorders and is commonly de novo (PMID: 32203253). It has been identified as a de novo occurrence with confirmed parental relationships in at least one individual and as a de novo occurrence with unconfirmed parental relationships in multiple individuals with PAX2-related renal disorders (PMID: 34696790; 32203253, SCV000693891.1, SCV002059196.1). The variant has been reported to segregate with renal disorders in at least four individuals from two unrelated families (PMID: 32203253, 34696790). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PS2/PM6_VeryStrong, PP1 (less)
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Renal coloboma syndrome
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Neuberg Centre For Genomic Medicine, NCGM
Accession: SCV005042846.1
First in ClinVar: May 12, 2024 Last updated: May 12, 2024 |
Comment:
The frameshift c.76dup p.Val26GlyfsTer28 variant in the PAX2 gene has been reported in individuals affected with Papillorenal syndrome Ohtsubo H et al., 2012. It has … (more)
The frameshift c.76dup p.Val26GlyfsTer28 variant in the PAX2 gene has been reported in individuals affected with Papillorenal syndrome Ohtsubo H et al., 2012. It has also been observed to segregate with disease in related individuals. This variant is reported with the allele frequency 0.002% in the gnomAD Exomes and novel in 1000 Genomes. It is submitted to ClinVar as Pathogenic multiple submissions. This variant causes a frameshift starting with codon Valine 26, changes this amino acid to Glycine residue, and creates a premature Stop codon at position 28 of the new reading frame, denoted p.Val26GlyfsTer28. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. (less)
Clinical Features:
Abnormality of the kidney (present)
|
|
Pathogenic
(Aug 05, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Focal segmental glomerulosclerosis 7
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
de novo
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV005093820.1
First in ClinVar: Aug 11, 2024 Last updated: Aug 11, 2024 |
Clinical Features:
Renal hypoplasia (present) , Abnormal myocardium morphology (present) , Cardiomegaly (present) , Tricuspid regurgitation (present)
|
|
Pathogenic
(Mar 01, 2012)
|
no assertion criteria provided
Method: literature only
|
PAPILLORENAL SYNDROME
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000035061.2
First in ClinVar: Apr 04, 2013 Last updated: Apr 27, 2014 |
Comment on evidence:
In 2 brothers with the renal-coloboma syndrome (120330) reported by Weaver et al. (1988), Sanyanusin et al. (1995) found insertion of a G at position … (more)
In 2 brothers with the renal-coloboma syndrome (120330) reported by Weaver et al. (1988), Sanyanusin et al. (1995) found insertion of a G at position 619 (619insG) of the PAX2 gene (codon 26) resulting in a frameshift and predicted to result in a truncated PAX2 protein due to introduction of a termination codon 26 amino acids downstream from the mutation. The mutation probably resulted in haploinsufficiency of PAX2. The mutation was not present in the mother; the father was not available for study. Schimmenti et al. (1997) noted that previously reported patients with renal-coloboma syndrome had ocular and/or renal abnormalities, but PAX2 expression patterns suggested that auditory and CNS abnormalities may be additional features of the condition. To determine whether additional clinical features are associated with PAX2 mutations, they used PCR-SSCP to identify PAX2 gene mutations in patients with a variety of abnormalities. They detected a 1-bp insertion (G) in exon 2 of the PAX2 gene in 3 patients from 2 different families. The insertion occurred in a sequence of 7 G's, a sequence that appears to be particularly prone to mutation through slippage during DNA replication. Their patient 657 was a 25-year-old male who was moderately mentally retarded and microcephalic. At age 3 months, he presented with esotropia, exophthalmos, and lack of direct pupillary response to light stimulation of the left eye. The anterior segment of both eyes was normal. The fundi of both eyes were lightly pigmented. In the left eye, no optic nerve head and no retinal vessels were present. In the area where the disc is normally present, a gray structure with an overlying pit was evident. In the right eye, milder changes were observed, including a hypoplastic optic disc with a pit surrounded by pigment, diffuse atrophic changes of the retina, and retinochoroidal colobomas in the inferior fundus. Electroretinography was subnormal in the right eye; responses were electronegative in the left eye. At age 7 years, ultrasound and CT scans showed a retrobulbar cyst behind the left microphthalmic eye. At age 4 months, renal insufficiency was noted with hypoplastic kidneys. The patient's mother, a 48-year-old woman, had hypertension and proteinuria during 2 pregnancies at ages 19 and 22 years. End-stage renal disease and bilateral renal hypoplasia were diagnosed at age 24 years, and she was maintained on hemodialysis waiting for a second renal transplant after failure of her first transplant. Bilateral opacities of the anterior and posterior lens capsules were noted and required surgical treatment. Fundi showed hypoplastic optic discs bilaterally. Visual acuity was 20/30 in both eyes. She had normal intelligence, normal hearing, and no history of seizures. Physical examination was significant for soft skin, which was also noted in her son. The third patient was a 20-year-old female who had developed proteinuria at age 3 years and progressed to end-stage renal disease. Renal biopsy at age 10 years showed focal segmental glomerulosclerosis and renal ultrasound showed small kidneys. Renal transplant from her brother at age 18 years was rejected and the patient was maintained on hemodialysis awaiting a cadaveric transplant. Bilateral optic nerve colobomas were discovered at the age of 6 years. At age 20, she had 'relatively good vision' and did not require corrective lenses. Bilateral inguinal hernias had been repaired at age 6 years. Tellier et al. (1998) demonstrated that this relatively frequent and recurrent mutation can produce either isolated renal hypoplasia or renal hypoplasia associated with microphthalmia and retinal degeneration. The same mutation is responsible for the Pax2 1Neu mutant, a mouse model for human RCS. Amiel et al. (2000) described a family in which 3 sibs had renal-coloboma syndrome and the PAX2 619insG mutation. The unaffected parents did not carry the mutation, suggesting the presence of germline mosaicism. The study of a PAX2 intragenic DNA microsatellite marker showed that the mutation was of paternal origin (false paternity was excluded by the study of polymorphic markers). In a family in which at least 7 members had renal-coloboma syndrome, Ford et al. (2001) identified the 619insG frameshift mutation in all of those affected. The authors noted remarkable variability in both the ocular and renal manifestations. Bower et al. (2012) reviewed published cases of PAX2 mutations as well as data from a consortium of 3 laboratories and stated that the 619insG mutation, which they designated 76dup (Val26Cysfs*28), was the most common recurrent mutation. Their nucleotide numbering reflected the cDNA transcript with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence. (less)
|
|
Pathogenic
(May 27, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Congenital anomaly of kidney and urinary tract
Affected status: yes
Allele origin:
unknown
|
Sydney Genome Diagnostics, Children's Hospital Westmead
Accession: SCV001449395.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This individual is heterozygous for a known pathogenic variant c.76dup (also known as 619insG) in the PAX2 gene. This frameshifting variant is predicted to create … (more)
This individual is heterozygous for a known pathogenic variant c.76dup (also known as 619insG) in the PAX2 gene. This frameshifting variant is predicted to create a premature stop codon p.(Val26Glyfs*28) and may result in a null allele due to nonsense-mediated mRNA decay. The variant has been widely reported to be a papillorenal syndrome causing variant (OMIM * 167409; Bower et al Hum Mutat. 2012 Mar;33(3):457-66; Amiel et al Eur J Hum Genet. 2000 Nov;8(11):820-6). This variant is considered to be pathogenic according to the ACMG guidelines. (less)
Number of individuals with the variant: 1
|
|
Likely pathogenic
(Apr 17, 2019)
|
no assertion criteria provided
Method: literature only
|
Steroid-resistant nephrotic syndrome
Focal segmental glomerulosclerosis
Affected status: yes
Allele origin:
germline
|
Yale Center for Mendelian Genomics, Yale University
Study: Yale Center for Mendelian Genomics
Accession: SCV002106627.1 First in ClinVar: Mar 28, 2022 Last updated: Mar 28, 2022 |
|
|
Pathogenic
(Apr 09, 2024)
|
no assertion criteria provided
Method: clinical testing
|
PAX2-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004114045.3
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The PAX2 c.76dupG variant is predicted to result in a frameshift and premature protein termination (p.Val26Glyfs*28). This variant has been reported in many individuals to … (more)
The PAX2 c.76dupG variant is predicted to result in a frameshift and premature protein termination (p.Val26Glyfs*28). This variant has been reported in many individuals to be pathogenic for papillorenal syndrome, renal coloboma syndrome, and congenital anomalies of the kidney and urinary tract (Bower et al. 2012. PubMed ID: 22213154; c.69_70insG in Thomas et al. 2011. PubMed ID: 21380624; Iwafuchi et al. 2016. PubMed ID: 27226968; Sato et al. 2013. PubMed ID: 23966757; Madariaga et al. 2013. PubMed ID: 23539225). Individuals heterozygous for the c.76dup variant have highly variable clinical presentation and interfamilial variability is also observed (see for example Iwafuchi et al. 2016. PubMed ID: 27226968 and Sato et al. 2013. PubMed ID: 23966757). This variant is reported in 0.010% of alleles in individuals of Ashkenazi Jewish descent in gnomAD and is reported in ClinVar by several outside labs as pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/156297). Frameshift variants in PAX2 are expected to be pathogenic. This variant is interpreted as pathogenic. (less)
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Study: VKGL Data-share Consensus
Accession: SCV001797545.1 First in ClinVar: Aug 21, 2021 Last updated: Aug 21, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001741995.3 First in ClinVar: Jul 07, 2021 Last updated: Sep 08, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
unknown
|
ClinVar Staff, National Center for Biotechnology Information (NCBI)
Accession: SCV000189505.1
First in ClinVar: Oct 06, 2014 Last updated: Oct 06, 2014
Comment:
Based on information supplied by Graeme Grimes.
|
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Renal coloboma syndrome
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000192001.2
First in ClinVar: Nov 22, 2014 Last updated: Oct 01, 2022 |
|
|
not provided
(-)
|
no classification provided
Method: phenotyping only
|
Renal coloboma syndrome
Affected status: unknown
Allele origin:
unknown
|
GenomeConnect, ClinGen
Accession: SCV000840110.1
First in ClinVar: Nov 22, 2014 Last updated: Nov 22, 2014 |
Comment:
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical … (more)
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. (less)
Clinical Features:
Abnormality of the optic nerve (present) , Myopia (present) , Vertigo (present) , Tinnitus (present) , Abnormality of urine homeostasis (present) , Abnormality of reproductive … (more)
Abnormality of the optic nerve (present) , Myopia (present) , Vertigo (present) , Tinnitus (present) , Abnormality of urine homeostasis (present) , Abnormality of reproductive system physiology (present) , Abnormal renal morphology (present) , Abnormal renal physiology (present) (less)
Age: 30-39 years
Sex: male
Method: Sanger Sequencing
Testing laboratory: GeneDx
Date variant was reported to submitter: 2017-07-06
Testing laboratory interpretation: Pathogenic
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Detection of De Novo PAX2 Variants and Phenotypes in Chinese Population: A Single-Center Study. | Xiong HY | Frontiers in genetics | 2022 | PMID: 35444690 |
Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. | Domingo-Gallego A | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2022 | PMID: 33532864 |
Phenotypic spectrum and genetics of PAX2-related disorder in the Chinese cohort. | Yang X | BMC medical genomics | 2021 | PMID: 34696790 |
Clinical and genetic variability of PAX2-related disorder in the Japanese population. | Rossanti R | Journal of human genetics | 2020 | PMID: 32203253 |
Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children. | Vivante A | Pediatric nephrology (Berlin, Germany) | 2019 | PMID: 31001663 |
PAX2-Related Disorder. | Adam MP | - | 2018 | PMID: 20301624 |
Diverse Renal Phenotypes Observed in a Single Family with a Genetic Mutation in Paired Box Protein 2. | Iwafuchi Y | Case reports in nephrology and dialysis | 2016 | PMID: 27226968 |
Mutations in PAX2 associate with adult-onset FSGS. | Barua M | Journal of the American Society of Nephrology : JASN | 2014 | PMID: 24676634 |
Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. | Hwang DY | Kidney international | 2014 | PMID: 24429398 |
Alport-like glomerular basement membrane changes with renal-coloboma syndrome. | Ohtsubo H | Pediatric nephrology (Berlin, Germany) | 2012 | PMID: 22350371 |
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. | Bower M | Human mutation | 2012 | PMID: 22213154 |
PAX2 gene mutation in a family with isolated renal hypoplasia. | Nishimoto K | Journal of the American Society of Nephrology : JASN | 2001 | PMID: 11461952 |
Renal-coloboma syndrome: prenatal detection and clinical spectrum in a large family. | Ford B | American journal of medical genetics | 2001 | PMID: 11241473 |
PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism. | Amiel J | European journal of human genetics : EJHG | 2000 | PMID: 11093271 |
Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. | Schimmenti LA | American journal of human genetics | 1997 | PMID: 9106533 |
Mutation of PAX2 in two siblings with renal-coloboma syndrome. | Sanyanusin P | Human molecular genetics | 1995 | PMID: 8589702 |
Optic nerve coloboma associated with renal disease. | Weaver RG | American journal of medical genetics | 1988 | PMID: 3377002 |
Tellier, A.-L., Amiel, J., Salomon, R., Jolly, D., Delezoide, A.-L., Auge, J., Gubler, M.-C., Munnich, A., Lyonnet, S., Antignac, C., Vekemans, M., Broyer, M., Attie-Bitach, T. PAX2 expression during early human development and its mutations in renal hypoplasia with or without coloboma. (Abstract) Am. J. Hum. Genet. 63 (suppl.): A7-only, 1998. | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs75462234 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.